These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7883799)

  • 1. The D-type cyclins and their role in tumorigenesis.
    Peters G
    J Cell Sci Suppl; 1994; 18():89-96. PubMed ID: 7883799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-type cyclin-dependent kinase activity in mammalian cells.
    Matsushime H; Quelle DE; Shurtleff SA; Shibuya M; Sherr CJ; Kato JY
    Mol Cell Biol; 1994 Mar; 14(3):2066-76. PubMed ID: 8114738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK; Medina D
    Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
    Kato JY; Sherr CJ
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11513-7. PubMed ID: 7505440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
    Meyerson M; Harlow E
    Mol Cell Biol; 1994 Mar; 14(3):2077-86. PubMed ID: 8114739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.
    Kato J; Matsushime H; Hiebert SW; Ewen ME; Sherr CJ
    Genes Dev; 1993 Mar; 7(3):331-42. PubMed ID: 8449399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
    Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
    Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin E, a redundant cyclin in breast cancer.
    Gray-Bablin J; Zalvide J; Fox MP; Knickerbocker CJ; DeCaprio JA; Keyomarsi K
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15215-20. PubMed ID: 8986790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins.
    Ewen ME; Sluss HK; Sherr CJ; Matsushime H; Kato J; Livingston DM
    Cell; 1993 May; 73(3):487-97. PubMed ID: 8343202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical interaction of the retinoblastoma protein with human D cyclins.
    Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
    Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple functions of D-type cyclins can antagonize pRb-mediated suppression of proliferation.
    Baker GL; Landis MW; Hinds PW
    Cell Cycle; 2005 Feb; 4(2):330-8. PubMed ID: 15684604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.
    Tam SW; Theodoras AM; Shay JW; Draetta GF; Pagano M
    Oncogene; 1994 Sep; 9(9):2663-74. PubMed ID: 8058330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-type cyclins.
    Sherr CJ
    Trends Biochem Sci; 1995 May; 20(5):187-90. PubMed ID: 7610482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of G1 progression by D-type cyclins: key event for cell proliferation.
    Kato JY
    Leukemia; 1997 Apr; 11 Suppl 3():347-51. PubMed ID: 9209386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
    Lukas J; Müller H; Bartkova J; Spitkovsky D; Kjerulff AA; Jansen-Dürr P; Strauss M; Bartek J
    J Cell Biol; 1994 May; 125(3):625-38. PubMed ID: 8175885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.